Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

DYAX $25.68 8.9300 +53.31%
IMDZ $25.70 4.5900 +21.74%
LOXO $13.59 1.1400 +9.16%
TLOG $4.52 0.1400 +3.20%
CTIC $1.85 0.0400 +2.21%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ZIOP $9.97 -0.8000 -7.43%
CERU $8.51 -0.5050 -5.60%
XLRN $36.01 -2.0500 -5.39%
BCRX $8.58 -0.4500 -4.98%
CRIS $2.28 -0.1190 -4.96%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

Breast Biopsies Leave Room for Doubt, Study Finds

(New York Times) Mar 17, 2015 - Breast biopsies are good at telling the difference between healthy tissue and cancer, but less reliable for identifying more subtle abnormalities, a new study finds.
read article 



Cancer Care in America: A Shifting Landscape

(ASCO) Mar 17, 2015 - The U.S. cancer care system faces tremendous turbulence while dealing with growing numbers of cancer patients and survivors, mounting pressures to control rising healthcare costs, and widespread oncology practice transformation, reports a new study by the American Society of Clinical Oncology (ASCO).
read press release 



Pharmacyclics Cancer Drug Successful as Combination Therapy: Independent Panel

(Reuters) Mar 16, 2015 - An independent panel recommended unblinding a late-stage study testing Pharmacyclics Inc and Johnson & Johnson's Imbruvica, after the treatment was successful against two similar forms of cancer in combination with other drugs.
read article 



Novartis' Jakavi Gets Yes in Europe

(PharmaTimes [UK]) Mar 17, 2015 - Novartis has been given the green light in Europe for Jakavi to treat a rare blood cancer.
read article 



Merck Expects to Be Denied Approval for Sugammadex Injection Again

(Reuters) Mar 13, 2015 - Merck & Co Inc said it expects its long-delayed drug to reverse the effects of anesthesia to be denied U.S. approval after U.S. regulators said they need to conduct more site inspections related to a study of the drug.
read article 



‘Doc Fix’ Is Latest Spending Battle for Conservatives

(CQ Roll Call) Mar 16, 2015 - As the House returns Monday for its first legislative week after Republicans caved on the Department of Homeland Security funding bill, GOP leaders are gearing up for their next battle: the Sustainable Growth Rate.
read article 



American Association for Cancer Research Welcomes New Board of Directors, Nominating Committee Members

(AACR) Mar 13, 2015 - The members of the American Association for Cancer Research (AACR) have elected five members to serve on the AACR board of directors for the 2015-2018 term and four members to serve on the nominating committee for the 2015-2017 term.
read press release 



Baxter's Haemophilia Drug Hits PhIII Targets

(PharmaTimes [UK]) Mar 13, 2015 - Baxter’s investigational haemophilia treatment was successful in controlling bleeding episodes in a late-stage clinical trial with patients who develop inhibitors to clotting factor replacement therapies.
read article 



Surgeons Announce World’s First Successful Penis Transplant

(Washington Post/Speaking of Science) Mar 13, 2015 - In a nine-hour surgery, a South African medical team successfully transplanted the penis of a dead donor to a young man without one.
read article (free registration required) 



AstraZeneca Heart Drug Proves Worthy, Elevating Sales Potential

(Chicago Tribune/Bloomberg) Mar 15, 2015 - AstraZeneca's Brilinta reduces the risk of death from heart attack or stroke long after an initial attack, according to research that may bring billions of dollars to the company as more people use the drug for extended periods.
read article 



Medicare Panel Faults Payment Fix as Too Weak

(Wall Street Journal) Mar 15, 2015 - A planned overhaul of Medicare payments to long-term hospitals doesn’t go far enough, a congressional advisory panel said, and it called for further changes to discourage timing patients’ discharges to financial incentives.
read article (paid subscription required) 



Tests of Cholesterol Drugs Offer Hope of Reducing Heart Attacks and Strokes

(New York Times) Mar 15, 2015 - A new class of experimental cholesterol drugs might sharply reduce the risk of heart attacks and strokes, researchers reported on Sunday, citing what they described as preliminary evidence.
read article 



Washington’s Skin Cancer Hostages

(Wall Street Journal/Opinion) Mar 13, 2015 - The FDA is defying Congress and Obama on better sunscreens.
read article (paid subscription required) 



Provectus Biopharmaceuticals’ Amended Protocol of PV-10 for Phase 3 Study as Treatment for Melanoma Now Available Online

(MarketWatch) Mar 16, 2015 - Study timeline remains unchanged, IRB approval process begun; minor changes to patient eligibility, endpoint assessment and crossover of patients.
read article 



Recent Studies Of Mammography Use Shockingly Old Data

(Forbes) Mar 16, 2015 - Researchers today are analyzing our grandmothers’ mammograms to inform women’s health and screening decisions today.
read article 



Appraisal Processes Prevent Patients From Accessing New Anti-cancers, Report Claims

(The Pharmaceutical Journal [UK]) Mar 13, 2015 - Patients living in countries where the cost-effectiveness of a drug is based on the cost per quality-adjusted life years (QALYs) have less access to new cancer drugs compared to countries that do not, a report claims.
read article 



ASCO Submits Comments on Clinical Trial Participation for Medicare Advantage Enrollees

(ASCO in Action) Mar 13, 2015 - ASCO recently submitted comments to the Centers for Medicare and Medicaid Services (CMS) in response to its Advance Notice of Methodological Changes for Calendar Year (CY) 2016 for Medicare Advantage (MA) and 2016 Call Letter.
read article 



NCCN Publishes New Guidelines for Smoking Cessation

(NCCN) Mar 13, 2015 - Written for the treatment of smokers diagnosed with cancer, the NCCN Guidelines® for Smoking Cessation recommends treatment plans that include evidence-based pharmacotherapy and behavior therapy.
read press release 



20 Years of Improving Cancer Care Together – An NCCN Roundtable Discussion

(NCCN) Mar 13, 2015 - On March 12, 2015, as part of its 20th Annual Conference: Advancing the Standard of Cancer Care™, the National Comprehensive Cancer Network® (NCCN®) featured the commemorative event, 20 Years of Improving Cancer Care Together – An NCCN Roundtable Discussion.
read press release 



A True Fountain-Of-Youth Drug Combo?

(Forbes) Mar 16, 2015 - A new study shows dramatic anti-aging effects using a combination of two compounds: a common supplement and a cancer chemotherapeutic. If the results in mice carry over to humans, this could transform our treatment of age-related diseases.
read article 



Penn Vet Team Points to New Colon Cancer Culprit

(Penn News) Mar 16, 2015 - A team of researchers from the University of Pennsylvania has found evidence of a new culprit in colon cancer, a protein called MSI2.
read press release 



Study Identifies “Lethal” Subtype of Prostate Cancer

(UCCC/In the Lab blog) Mar 16, 2015 - A University of Colorado Cancer Center study published in the journal Cancer Research defines a new, distinct subtype of “lethal” prostate cancer marked by the loss of two genes, MAP3K7 and CHD1.
read article 



ASU Researchers Search for Telltale Signs of Ovarian Cancer

(ASU News) Mar 13, 2015 - Researchers at Arizona State University’s Biodesign Institute are working toward the development of biomarkers — blood-borne signals that can reveal the presence of diseases like cancer before a patient displays any outward symptoms.
read article 



Can MRI Be Used to Identify 'Biologically Inert' DCIS?

(Medscape Medical News) Mar 13, 2015 - MRI of the breast can detect more biologically relevant ductal carcinomas in situ (DCIS) than mammography and could be used to stratify risk for a more targeted therapeutic approach, new findings suggest.
read article (free registration required) 



MI Survivors May Be at Risk for Lung, Bladder, Other Cancers

(Heartwire from Medscape) Mar 15, 2015 - Although not exactly sure of the underlying mechanism or whether other factors are at play, researchers from Denmark note that patients who survive an MI may be at significant risk for overall and specific types of cancer.
read article (free registration required)